Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
SPRED2
Introduction
Sprouty-related, EVH1 domain-containing protein 2 is a protein that in humans is encoded by the SPRED2 gene.[1]
Function
Function
SPRED2 is a member of the Sprouty (see SPRY1)/SPRED family of proteins that regulate growth factor-induced activation of the MAP kinase cascade (see MAPK1[1]).
Further reading
Further reading
- Andersson B, Wentland MA, Ricafrente JY, et al. (1996). “A “double adaptor” method for improved shotgun library construction”. Anal. Biochem. 236 (1): 107–13. doi:10.1006/abio.1996.0138. PMID 8619474.
- Yu W, Andersson B, Worley KC, et al. (1997). “Large-scale concatenation cDNA sequencing”. Genome Res. 7 (4): 353–8. doi:10.1101/gr.7.4.353. PMC 139146. PMID 9110174.
- Wakioka T, Sasaki A, Kato R, et al. (2001). “Spred is a Sprouty-related suppressor of Ras signalling”. Nature. 412 (6847): 647–51. doi:10.1038/35088082. PMID 11493923.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Kato R, Nonami A, Taketomi T, et al. (2003). “Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation”. Biochem. Biophys. Res. Commun. 302 (4): 767–72. doi:10.1016/S0006-291X(03)00259-6. PMID 12646235.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Nobuhisa I, Kato R, Inoue H, et al. (2004). “Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP kinase activation”. J. Exp. Med. 199 (5): 737–42. doi:10.1084/jem.20030830. PMC 2213301. PMID 14981116.
- Miyoshi K, Wakioka T, Nishinakamura H, et al. (2004). “The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization”. Oncogene. 23 (33): 5567–76. doi:10.1038/sj.onc.1207759. PMID 15184877.
- Zimmermann J, Jarchau T, Walter U, et al. (2005). “1H, 13C and 15N resonance assignment of the human Spred2 EVH1 domain”. J. Biomol. NMR. 29 (3): 435–6. doi:10.1023/B:JNMR.0000032526.17586.8c. PMID 15213456.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Engelhardt CM, Bundschu K, Messerschmitt M, et al. (2005). “Expression and subcellular localization of Spred proteins in mouse and human tissues”. Histochem. Cell Biol. 122 (6): 527–38. doi:10.1007/s00418-004-0725-6. PMID 15580519.
- King JA, Straffon AF, D’Abaco GM, et al. (2005). “Distinct requirements for the Sprouty domain for functional activity of Spred proteins”. Biochem. J. 388 (Pt 2): 445–54. doi:10.1042/BJ20041284. PMC 1138951. PMID 15683364.
- Bundschu K, Knobeloch KP, Ullrich M, et al. (2005). “Gene disruption of Spred-2 causes dwarfism”. J. Biol. Chem. 280 (31): 28572–80. doi:10.1074/jbc.M503640200. PMID 15946934.
- Yoshida T, Hisamoto T, Akiba J, et al. (2006). “Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors”. Oncogene. 25 (45): 6056–66. doi:10.1038/sj.onc.1209635. PMID 16652141.
- Lock P, I ST, Straffon AF, et al. (2007). “Spred-2 steady-state levels are regulated by phosphorylation and Cbl-mediated ubiquitination”. Biochem. Biophys. Res. Commun. 351 (4): 1018–23. doi:10.1016/j.bbrc.2006.10.150. PMID 17094949.